** Shares of Amplia Therapeutics Ltd (ATX) fall as much as 8.8% to A$0.26, their worst session since Nov 19, 2020
** The drug developer plans sales of 16.59 mln new shares to new and existing institutional investors, raising A$3.8 mln ($2.94 mln) to fund clinical trials in pancreatic cancer and pulmonary fibrosis
** Says the new shares will be issued at A$0.23 apiece, representing 10% discount to the 15-day volume weighted price of shares traded up to April 29
** The main stock index S&P/ASX 200 (xjo) climbs 0.4% ** As of last close, stock up 18.% this year ($1 = 1.2923 Australian dollars)
(Reuters Messaging: [email protected])
News: ATX BUZZ-Australia's Amplia Therapeutics falls most in near 6 months on discounted share sale...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $84.65M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 14.8¢ | $148.7K | 950.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 514529 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 531002 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| ATX (ASX) Chart |